Skip to main content

Advertisement

SpringerLink
Log in

Untreated hepatitis C could lead to annual costs of $US85 billion in the US

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Vertex Pharmaceuticals Incorporated.New Report Forecasts Hepatitis C Virus Epidemic Among Baby Boomers; Untreated HCV Progressing to Severe Liver Disease Seen Driving U.S. Costs to $85 Billion. Media Release: 19 May 2009. Available from: URL: http://www.vrtx.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Untreated hepatitis C could lead to annual costs of $US85 billion in the US. Pharmacoecon. Outcomes News 579, 12 (2009). https://doi.org/10.2165/00151234-200905790-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00027

Keywords

Search

Navigation